K Hirashima

576 total citations
44 papers, 465 citations indexed

About

K Hirashima is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, K Hirashima has authored 44 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Hematology and 10 papers in Genetics. Recurrent topics in K Hirashima's work include Neutropenia and Cancer Infections (13 papers), Acute Myeloid Leukemia Research (11 papers) and Blood disorders and treatments (7 papers). K Hirashima is often cited by papers focused on Neutropenia and Cancer Infections (13 papers), Acute Myeloid Leukemia Research (11 papers) and Blood disorders and treatments (7 papers). K Hirashima collaborates with scholars based in Japan, United States and South Korea. K Hirashima's co-authors include Masami Bessho, S Asano, Hisamaru Hirai, Takayuki Abe, I Murohashi, Y Yoshida, T Hotta, Keisuke Toyama, Kazuma Ohyashiki and A Kuramoto and has published in prestigious journals such as Leukemia, Supportive Care in Cancer and American Journal of Hematology.

In The Last Decade

K Hirashima

41 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Hirashima Japan 12 295 134 99 99 78 44 465
Y Yoshida Japan 12 309 1.0× 66 0.5× 134 1.4× 113 1.1× 48 0.6× 45 515
Christina Gasparetto United States 11 291 1.0× 157 1.2× 129 1.3× 75 0.8× 38 0.5× 16 456
S Furusawa Japan 11 226 0.8× 57 0.4× 129 1.3× 90 0.9× 69 0.9× 35 396
JH Bourhis United States 8 437 1.5× 136 1.0× 151 1.5× 77 0.8× 44 0.6× 10 507
A Rambaldi United States 7 236 0.8× 138 1.0× 120 1.2× 45 0.5× 58 0.7× 8 560
Henriëtte M. Goselink Netherlands 10 272 0.9× 111 0.8× 80 0.8× 83 0.8× 46 0.6× 18 464
BR Blazar United States 10 355 1.2× 156 1.2× 56 0.6× 104 1.1× 48 0.6× 13 528
IM Chen United States 5 309 1.0× 187 1.4× 164 1.7× 80 0.8× 24 0.3× 8 506
Fliedner Tm Germany 11 146 0.5× 96 0.7× 127 1.3× 82 0.8× 44 0.6× 41 446
Sairah Alvi United States 11 461 1.6× 51 0.4× 208 2.1× 128 1.3× 50 0.6× 13 560

Countries citing papers authored by K Hirashima

Since Specialization
Citations

This map shows the geographic impact of K Hirashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Hirashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Hirashima more than expected).

Fields of papers citing papers by K Hirashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Hirashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Hirashima. The network helps show where K Hirashima may publish in the future.

Co-authorship network of co-authors of K Hirashima

This figure shows the co-authorship network connecting the top 25 collaborators of K Hirashima. A scholar is included among the top collaborators of K Hirashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Hirashima. K Hirashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murohashi, I, Fumiharu Yagasaki, K. Itoh, et al.. (2002). Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma. Annals of Hematology. 81(3). 140–146. 24 indexed citations
2.
Takagi, Takeshi, Morio Sawamura, M Kashimura, et al.. (2001). Clinical benefits of lenograstim in patients with neutropenia due to chemotherapy for multiple myeloma (MM). Supportive Care in Cancer. 9(5). 397–399. 3 indexed citations
3.
Handa, Ajay, et al.. (2000). Expression of functional granulocyte colony-stimulating factor receptors on human B-lymphocytic leukemia cells. Annals of Hematology. 79(3). 127–131. 6 indexed citations
4.
Endo, Kazuhiro, Yoshiyuki Kobayashi, Nobuyuki Kawai, et al.. (1999). Non-Hodgkin's Lymphoma Complicated by Recurrent Intractable Generalized Herpes Zoster Responsive to Long-term Acyclovir Therapy. Kansenshogaku zasshi. 73(4). 341–345. 2 indexed citations
5.
Matsuda, Akihisa, Itsuro Jinnai, Fumiharu Yagasaki, et al.. (1999). New system for assessing the prognosis of refractory anemia patients. Leukemia. 13(11). 1727–1734. 13 indexed citations
6.
Matsuda, Akihisa, Itsuro Jinnai, Fumiharu Yagasaki, et al.. (1998). Refractory anemia with severe dysplasia: clinical significance of morphological features in refractory anemia. Leukemia. 12(4). 482–485. 26 indexed citations
7.
Itoh, K., I Murohashi, Itsuro Jinnai, et al.. (1997). [Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia in a patient who died of progressive peripheral polyneuritis and cerebral dysfunction].. PubMed. 38(2). 117–23. 1 indexed citations
8.
Aida, K, Tomohisa Horibe, Ajay Handa, et al.. (1997). [Plasma cell leukemia associated with monocytosis].. PubMed. 38(7). 604–9. 1 indexed citations
9.
Matsuda, Akihiko, S Kusumoto, Kei Ito, et al.. (1996). [Refractory anemia with excess of blasts (RAEB) with a high level of HbF that preceded apparent pancytopenia].. PubMed. 37(1). 60–4. 1 indexed citations
10.
Nakajima, Hideaki, Yuji Ikeda, K Hirashima, et al.. (1995). [A randomized controlled study of rG.CSF in patients with neutropenia after induction therapy for acute myelogenous leukemia. (rG.CSF Clinical Study Group)].. PubMed. 36(6). 597–605. 8 indexed citations
11.
Murohashi, I, et al.. (1995). Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.. PubMed. 23(9). 970–7. 30 indexed citations
12.
Bessho, Masami, et al.. (1994). Suppression of the development of murine myeloid leukemia with granulocyte colony-stimulating factor by inducing apoptosis of leukemic cells.. PubMed. 8(7). 1185–90. 10 indexed citations
13.
Ikebuchi, Kenji, et al.. (1992). Interleukin-3 and granulocyte colony-stimulating factor as survival factors in murine hemopoietic stem cells in vitro.. PubMed. 55(2). 139–45. 13 indexed citations
14.
Yoshida, Y, S Asano, K Hirashima, & Fumimaro Takaku. (1992). Clinical Use of Recombinant Human G-CSF. Aplastic Anemia (AA) and Myelodysplastic Syndromes (MDS). Journal of Nutritional Science and Vitaminology. 38(Special). 349–352. 1 indexed citations
15.
Cynshi, Osamu, K. Satoh, Yasushi Shimonaka, et al.. (1991). Reduced response to granulocyte colony-stimulating factor in W/Wv and Sl/Sld mice.. PubMed. 5(1). 75–7. 29 indexed citations
16.
Jinnai, Itsuro, S Kusumoto, Masami Bessho, et al.. (1990). Transformation of bilineal hybrid acute leukemia to acute lymphoid leukemia: A case report with serial analyses of cytogenetics and gene rearrangement. American Journal of Hematology. 35(2). 118–124. 6 indexed citations
17.
Asano, S, K Hirashima, Yoshitoku Yoshida, et al.. (1990). [Clinical effect of recombinant human granulocyte colony-stimulating factor on aplastic anemia].. PubMed. 31(9). 1456–62. 11 indexed citations
18.
Tamura, Mayuko, Kunihiro Hattori, Shun-ichi Hata, et al.. (1989). Effects of recombinant human granulocyte colony stimulating factor (rG-CSF) on murine myeloid leukemia: stimulation of proliferation of leukemic cells in vitro and inhibition of development of leukemia in vivo.. PubMed. 3(12). 853–8. 10 indexed citations
19.
Bessho, Mika, et al.. (1985). Comparison of effects of lipopolysaccharide (LPS) and granulocytosis-inducing tumor on LPS-resistant and LPS-sensitive mice.. PubMed. 48(6). 1350–6. 1 indexed citations
20.
Sonoda, Takashi, Chieko Hayashi, T Nakano, et al.. (1984). Poor response of Wv/Wx mice to a grafted neutrophilia-inducing, colony-stimulating-factor-producing tumor.. PubMed. 12(11). 850–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Y Yoshida Breakdown of academic impact, for papers by Christina Gasparetto Breakdown of academic impact, for papers by S Furusawa Breakdown of academic impact, for papers by JH Bourhis Breakdown of academic impact, for papers by A Rambaldi Breakdown of academic impact, for papers by Henriëtte M. Goselink Breakdown of academic impact, for papers by BR Blazar Breakdown of academic impact, for papers by IM Chen Breakdown of academic impact, for papers by Fliedner Tm Breakdown of academic impact, for papers by Sairah Alvi
Rankless by CCL
2026